Celgene (CELG) volatility elevated into acquiring Juno Therapeutics for approximately $87 per share in cash

Celgene (NASDAQ: CELG) January weekly call option implied volatility is at 46, February is at 33; compared to its 52-week range of 17 to 38 into acquiring Juno Therapeutics (JUNO) for approximately $87 per share in cash.

You May Also Be Interested In

• Apple (AAPL) call put ratio 1.1 calls 1 put into hosting a special event
• Oracle (ORCL) call put ratio 4 calls to 1 put with a focus on September 165 calls into quarter results
• Hedge Fund Giant Citadel Seeking To Buy Us Shale Oil Production Assets, Sources Say - Reuters